Key Points
Delhi-based pharmaceutical company Akums Drugs and Pharmaceuticals on Friday announced that it has been granted a patent for a room-temperature stable Oral Suspension of Hydroxyurea, designed to help manage Sickle Cell Disease (SCD)...
This new formulation is a breakthrough as it does not require refrigeration, unlike traditional Hydroxyurea solutions (500 mg), making it easier to store and distribute, especially in areas with limited access to cold storage, such as tribal regions in India...
Sickle Cell Disease is a genetic blood disorder that causes severe health issues like anemia and frequent pain episodes, affecting millions globally, especially in India and Africa...
"Our constant endeavour is to work on affordable medicines for Orphan Drugs and reduce dependency on imported medicines ensuring patient safety from rare diseases with timely and necessary treatment," Sanjeev Jain...
Most treatment options include pain relief drugs, blood transfusions to treat anemia and prevent stroke, hydroxyurea and sometimes, bone marrow or stem cell transplants...
You might be interested in
New cure for sickle cell disease coming soon
31, Oct, 23US food advisors will look at a gene therapy that could tackle the root cause of the sickle cell disease.
World Sickle Cell Day: Early signs and symptoms to look out for
19, Jun, 23World Sickle Cell Day is celebrated on June 19 to raise awareness about this genetic blood disorder and how people can manage their lifestyles
US approves two gene therapies for sickle cell disease
08, Dec, 23The U.S. Food and Drug Administration (FDA) on Friday approved a pair of gene therapies for sickle cell disease, including the first treatment based on the breakthrough CRISPR gene editing technology.
Cure for sickle cell disease on the horizon? US drug regulator is reviewing 2 new gene therapies
03, Nov, 23FDA is scheduled to review gene therapies from two American companies — Vertex Pharmaceuticals & Bluebird Bio Inc. If approved, therapies could mean a breakthrough for curing SCD.
US approves CRISPR gene-editing to treat sickle cell disease
10, Dec, 23The treatment for sickle cell disease uses the revolutionary gene-editing tool CRISPR to permanently change DNA in the patient's blood cells. | Health